| 1 |
How might using gold nanoparticles in electrochemical sensors enhance early-stage disease detection?
|
2. By increasing surface interactions for more accurate biomarker capture |
|
Gold nanoparticles provided a larger surface which allows more interaction of the biomarkers and accurate sensor detection. |
“ Nanomaterials such as nanoparticles, nanowires, nanotubes, quantum dots, and graphene, exhibit high surface area-to-volume ratios, unique electrical properties, and enhanced chemical reactivity making them ideal for use in electrochemical sensors.” |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 2 |
Which of the following best explains how label-free electrochemical sensors support point-of-care medical diagnostics?
|
|
|
Label-free electrochemical sensors detect the target molecule directly, which makes the diagnostic process faster. |
” A recent innovation demonstrates a rapid and label-free detection method for the PARP-1 protein in lung tissue (Jiang et al., 2023).” |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 3 |
Why is electrochemical transduction considered advantageous over optical transduction in medical diagnostic sensors?
|
2. It is more compatible with smartphone integration for remote analysis |
|
Electrochemical sensors create signal that a smart phone can access which allow the health monitoring easier. |
“ Integration with novel technologies such as smartphones and applications, digital biosensors enable rapid POC sensing. Instead of conventional devices (photodetector, photomultiplier tube), digital optical biosensors utilize smartphone cameras to detect target molecules. Generated signals are converted to digital read-outs with the help of accessories and smartphone applications. Lee et al. developed a lens-free digital sensor that is adapted for smartphones (Lee and Yang, 2014). ” |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 4 |
Which action would most effectively increase specificity in a sensor designed to detect a single disease biomarker?
|
3. Functionalizing the electrode with disease-specific aptamers |
|
Using aptamers that match disease biomarker help sensor catch only right thing, make sensor more specific. |
“ Biosensors incorporate a biological recognition element such as enzymes, antibodies, or nucleic acids, that specifically interacts with the target analyte .” |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 5 |
In a scenario where a sensor must detect ultra-low concentrations of a cancer biomarker, which modification is most critical?
|
3. Incorporating nanostructures to increase surface-to-volume ratio |
|
Nanostructures give more surface area for biomarker to stick, help sensor find very small amounts better. |
“ Nanomaterials such as nanoparticles, nanowires, and nanotubes can be precisely engineered to function effectively at the nanoscale. This capability allows for the construction of smaller, more efficient sensors that require less sample volume and reagent, making them more practical for clinical and field applications.” |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 6 |
Why might two electrochemical sensors using the same nanomaterial produce inconsistent results?
|
3. Variations in nanomaterial synthesis affect structural uniformity |
|
If nanomaterials made in different ways, their structures change. That make sensor results not always the same. |
“ Producing nanomaterial-based sensors at a commercial scale while maintaining performance consistency is a major challenge [76]. Advancements in nanomanufacturing techniques, such as roll-to-roll processing and three-dimensional printing, offer scalable solutions for producing nanomaterial-based sensors. ” |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 7 |
Which characteristic makes nanotechnology-based electrochemical sensors especially suitable for wearable medical devices?
|
3. They allow miniaturization without losing sensitivity |
|
Nanotechnology lets sensors be very small but still work well, so they fit easily in wearable devices. |
“ Nanotechnology-enhanced electrochemical sensors offer numerous advantages including improved sensitivity and specificity, the potential for miniaturization, and the capability for real-time monitoring.” |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 8 |
What would likely happen if the bioreceptor layer is poorly immobilized on the sensor surface?
|
3. Target biomolecules may not bind effectively, leading to weak or inaccurate signals |
|
If the bioreceptor is not fixed well, it can’t catch target molecules properly, so the sensor gives weak or wrong readings. |
“ When the target analyte interacts with the electrode it undergoes a redox (reduction-oxidation) reaction which causes electrons' transfers. This electron transfer generates an electrical signal proportional to the concentration of the analyte which can be measured and analyzed.” |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 9 |
Which modification would most directly enhance electron transfer in the sensor system?
|
2. Incorporating carbon nanotubes on the electrode surface |
|
Carbon nanotubes help electrons move better on the electrode, which makes the sensor work faster and clearer. |
“ Nanomaterials such as nanoparticles, nanowires, nanotubes, quantum dots, and graphene, exhibit high surface area-to-volume ratios, unique electrical properties, and enhanced chemical reactivity making them ideal for use in electrochemical sensors.” |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 10 |
How can digital sensing technologies best support personalized cancer care?
|
2. By collecting real-time data on patient-specific symptoms and responses |
|
Digital sensors gather live data about how each patient feels and reacts, helping doctors tailor treatments for that person. |
” Wearable sensors represent a rapidly evolving class of digital health tools that enable continuous, real-time physiological monitoring and are increasingly integrated with personalized healthcare systems.” |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 11 |
If a clinician needs to monitor fatigue and motion in cancer patients at home, which device should be prioritized?
|
2. Smart accelerometers in wearables |
|
Wearable accelerometers track movement and activity levels, making them ideal for monitoring fatigue and motion at home. |
“ One example is a study conducted by Panda et al., which utilizes smartphone accelerometers to track post-surgical recovery among cancer patients, offering a more personalized and objective measure of physical activity (Panda et al., 2020). ” |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 12 |
Why is combining sensor data with patient-reported outcomes (PROs) important in digital cancer care?
|
3. It allows a holistic understanding of patient experience |
|
Combining sensor data with patient say how they feel help see more about patient health and make care better. |
” By leveraging on the unique strengths of each modality, clinicians can obtain a comprehensive understanding of cancer's anatomical and physiological characteristics, facilitating personalized treatment strategies and improving patient outcomes. ” |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 13 |
A hospital invested in wearable digital monitoring but received low engagement from patients. Which of the following is most likely a contributing factor?
|
3. Low digital health literacy among patients |
|
If patients don't know how to use digital health tools well, they might not use the wearable monitors much. |
“ These enhancements are promising for the development of digital cancer diagnostics, however challenges remain in achieving universal standards, interoperability across diverse platforms, widespread adoption, and integration with clinical practice.” |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 14 |
Which future trend is most aligned with the development of emerging digital cancer platforms?
|
2. Creation of pocket-sized biosensing tools integrated with smartphones |
|
Future going make small tools that work with phones to help catch cancer fast and easy for people. |
“ The future of digital sensor platforms for cancer diagnosis has gained significance through innovative technologies that enhance detection methods' sensitivity, speed, and personalization. These future trends and potential breakthroughs could revolutionize early cancer detection and patient care. These upcoming advancements are mainly based on avenues such as multiplexed diagnostic platforms, functionalized nanomaterials, AI and digital medicine expansion, technological biomarker integration, real-time data collection, wearable technologies, and holistic approaches.” |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 15 |
How can real-time symptom monitoring positively affect treatment decisions?
|
3. By enabling rapid intervention before major deterioration |
|
Real-time watch patient symptoms let doctor help quick before patient get very bad. |
” These platforms enable the swift and accurate extraction of biomarkers, which are critical for the prompt diagnosis of cancer. In addition, wireless sensor network standardization is significant in providing interoperability between enhanced sensor platforms and facilitating seamless data transmission in cancer diagnostics (Petrenko, 2023).” |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 16 |
Which technology is best suited to detect rare cancer biomarkers with high precision?
|
1. Digital ELISA |
|
Digital ELISA can find very small amount of cancer markers with high accuracy. |
” Digital sensor platforms have significant regulatory challenges and approval processes that can prevent or make it difficult for their development and implementation for cancer diagnosis.” |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 17 |
Why is collaboration between data scientists and clinicians essential in digital oncology platforms?
|
3. Data insights require clinical validation for real-world use |
|
Data scientists make data but doctors check if data correct for real patient care. |
“Collaborations between nanotechnology experts and sensor manufacturers can lead to innovative integration methods that leverage the strengths of both fields.” |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 18 |
Which outcome is most likely when cancer patients actively use digital health tools to track their condition?
|
2. They engage more actively in shared treatment decisions |
|
Patients use digital tools help them join more in deciding their treatment with doctor. |
”By offering transformative improvements in diagnostic sensitivity, real-time data accessibility, and the potential for AI-driven insights, digital sensor platforms are poised to redefine oncological diagnostics, bridging the gap between early detection, precision medicine, and improved patient outcomes (Adir et al., 2020). Denis et al. (2017) reported that employing a weekly web-based symptom self-reporting system in clinic patients resulted in higher overall survival (19 months vs. 12 months) and improved performance level at the time of relapse.
” |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 19 |
A research team is developing a highly selective electrochemical sensor for detecting cancer biomarkers in blood. Based on the diagram, which combination of nanoparticle properties would most likely enhance both specificity and signal sensitivity?
|
2. Small spherical particles with antibody-conjugated targeting ligands |
|
Small particles with antibodies help catch the right cancer markers better and give stronger signals. |
“ For example, functionalized nanomaterials are currently being incorporated with biosensing platforms, thereby significantly enhancing both sensitivity and precision in the identification of cancer biomarkers derived from biopsies (Petrenko, 2023; Ser et al., 2023). These platforms enable the swift and accurate extraction of biomarkers, which are critical for the prompt diagnosis of cancer.” |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 20 |
A hospital is planning to adopt a single digital sensing platform to support a wide range of diagnostic applications. Based on the image, which of the following most justifies this decision?
|
2. One platform can be customized to detect toxins, cancer biomarkers, and heavy metals using interchangeable biorecognition elements |
|
One digital sensor platform can change parts to find many things like toxins or cancer markers. |
“ These platforms enable the swift and accurate extraction of biomarkers, which are critical for the prompt diagnosis of cancer. In addition, wireless sensor network standardization is significant in providing interoperability between enhanced sensor platforms and facilitating seamless data transmission in cancer diagnostics (Petrenko, 2023). ” |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|